Bertrand Richard Bugnon

Novartis Pharma Schweizerhalle AG engages in the development, production, and distribution of pharmaceutical, chemical, biotechnological, and medical-technical products. It also provides related services. The company was founded on June 18, 1938 and is headquartered in Pratteln, Switzerland.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Novartis Pharma Schweizerhalle AG engages in the development, production, and distribution of pharmaceutical, chemical, biotechnological, and medical-technical products. It also provides related services. The company was founded on June 18, 1938 and is headquartered in Pratteln, Switzerland.